STERIS plc
STEAPI behind this page
STE Q4 2026 request
Playground key active
/api/financials?ticker=STE&year=2026&quarter=4
Pick an endpoint and run the request.Income Statement
| Metric | Q4 2026 | Q4 2025 | YoY |
|---|---|---|---|
| Revenue | 1,588.4 | 1,480.5 | +7.3% |
Show Product Lines breakouts |
|||
| Capital equipment · AST | 6.1 | 16 | -61.9% |
| Capital equipment · Healthcare Segment | 337.1 | 318 | +6.0% |
| Consumables · Healthcare Segment | 376.4 | 352.7 | +6.7% |
| Product | 845.3 | 801.1 | +5.5% |
| Service | 743.1 | 679.5 | +9.4% |
| Service · AST | 283.1 | 257.8 | +9.8% |
| Service · Healthcare Segment | 422.7 | 386.4 | +9.4% |
Show Business Segments breakouts |
|||
| AST | 289.2 | 273.9 | +5.6% |
| AST · Operating Segments | 289.2 | 273.9 | +5.6% |
| Healthcare Segment | 1,136.3 | 1,057.2 | +7.5% |
| Healthcare Segment · Operating Segments | 1,136.3 | 1,057.2 | +7.5% |
Show Geography breakouts |
|||
| IE | 31.9 | 38.2 | -16.5% |
| US | 1,145.8 | 1,078.6 | +6.2% |
Show — breakouts |
|||
| Revenue | 162.9 | 149.5 | +9.0% |
| Revenue | 43.8 | 36.9 | +18.7% |
| Revenue | 216.4 | 206.1 | +5.0% |
| Revenue | 52.9 | 57.5 | -8.0% |
| Revenue | 162.9 | 149.5 | +9.0% |
| Cost of Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 456.8 | 433.4 | +5.4% |
| Service | 434.4 | 405.9 | +7.0% |
| Gross Profit | 697.1 | 641.2 | +8.7% |
| Selling, General & Administrative | 351.8 | 333.9 | +5.4% |
Show Business Segments breakouts |
|||
| AST · Operating Segments | 15.1 | 11.9 | +26.9% |
| Healthcare Segment · Operating Segments | 170.5 | 154.6 | +10.3% |
Show — breakouts |
|||
| Selling, General & Administrative | 17.3 | 15.4 | +12.3% |
| Research & Development | 28.8 | 27.6 | +4.3% |
Show Business Segments breakouts |
|||
| AST · Operating Segments | 0.8 | 1.1 | -27.3% |
| Healthcare Segment · Operating Segments | 25.3 | 23.7 | +6.8% |
Show — breakouts |
|||
| Research & Development | 2.5 | 2.7 | -7.4% |
| Restructuring Costs | -0.3 | 15.3 | -102.0% |
| Operating Expenses | 380.3 | 425 | -10.5% |
| Operating Income | 316.8 | 216.1 | +46.6% |
| Interest Expense | 15.1 | 17.2 | -12.2% |
| Other Non-Operating Income (Expense) | -2.8 | -3.5 | +20.0% |
| Non-Operating Income (Expense) | 12.3 | 18.8 | -34.6% |
| Income Before Taxes | 304.5 | 197.3 | +54.3% |
| Income Tax Expense (Benefit) | 84.2 | 50.5 | +66.7% |
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | 220.3 | 146.9 | +50.0% |
| Net Income | 220.3 | 146.1 | +50.8% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 0.1 | 0.4 | -75.0% |
| Retained Earnings | 220.2 | 145.6 | +51.2% |
| Net Income Loss Attributable To Noncontrolling Interest | 0.1 | 0.4 | -75.0% |
| Net Income | 220.2 | 145.6 | +51.2% |
| Income Loss From Continuing Operations Per Basic Share | 2.25 | 1.49 | +51.0% |
| EPS (Basic) | 2.25 | 1.49 | +51.0% |
| Income Loss From Continuing Operations Per Diluted Share | 2.24 | 1.48 | +51.4% |
| EPS (Diluted) | 2.24 | 1.47 | +52.4% |
| Common Stock Dividends Per Share Declared | 0.63 | 0.57 | +10.5% |
| Cost of Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| AST · Operating Segments | 142.2 | 138.8 | +2.4% |
| Healthcare Segment · Operating Segments | 657.4 | 599.2 | +9.7% |
Show — breakouts |
|||
| Cost of Revenue | 72.7 | 66.5 | +9.3% |
| Comprehensive Income | 149.8 | 227.6 | -34.2% |
| Other Comprehensive Income | -70.4 | 81.9 | -186.0% |
Show — breakouts |
|||
| Other Comprehensive Income | -249 | 45.5 | -647.3% |
| Other Comprehensive Income | -429.3 | 9.4 | -4667.0% |
| Wtd Avg Shares (Basic) | -0.1 | -0.1 | 0.0% |
| Wtd Avg Shares (Diluted) | -0.1 | -0.1 | 0.0% |
Balance Sheet
| Metric | Q4 2026 | Q4 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 439.6 | 171.7 | +156.0% |
| Accounts Receivable | 1,092.8 | 1,044 | +4.7% |
| Inventory | 631.8 | 581.3 | +8.7% |
| Other Prepaid Expense Current | 230.4 | 203.8 | +13.1% |
| Total Current Assets | 2,394.6 | 2,000.8 | +19.7% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,161.2 | 1,956.5 | +10.5% |
Show Geography breakouts |
|||
| IE | 88.1 | 74.9 | +17.6% |
| Other Foreign Entities [Member] | 978.7 | 872.9 | +12.1% |
| US | 1,094.4 | 1,008.7 | +8.5% |
| Operating Lease Right-of-Use Assets | 155.2 | 156.4 | -0.8% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | 1 | 4.6 | -78.3% |
| Goodwill | 4,194.8 | 4,095.7 | +2.4% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | 8.8 | 10.6 | -17.0% |
Show Reporting Unit breakouts |
|||
| AST | 1,482.3 | 1,415.4 | +4.7% |
| Health Care | 2,539 | 2,509.3 | +1.2% |
| Life Sciences | 173.5 | 170.9 | +1.5% |
| Other Non-Current Assets | 211.4 | 83 | +154.7% |
| Total Assets | 10,737.2 | 10,146.8 | +5.8% |
Show Business Segments breakouts |
|||
| AST · Segment Continuing Operations | 3,590.4 | 3,340.4 | +7.5% |
| Healthcare and Life Sciences · Segment Continuing Operations | 7,146.8 | 6,806.4 | +5.0% |
Show Statement Operating Activities Segment breakouts |
|||
| Segment Continuing Operations | 10,737.2 | 10,146.8 | +5.8% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 1,620 | 1,854.4 | -12.6% |
| Current Liabilities | |||
| Accounts Payable | 338.8 | 280.8 | +20.7% |
| Accrued Income Taxes Current | 28.6 | 21.5 | +33.0% |
| Employee Related Liabilities Current | 221.1 | 192.7 | +14.7% |
| Operating Lease Liability Current | 35.8 | 34.2 | +4.7% |
| Short Term Borrowings | 118.9 | 125 | -4.9% |
| Accrued Liabilities | 401.9 | 368.1 | +9.2% |
| Total Current Liabilities | 1,145 | 1,022.2 | +12.0% |
| Non-Current Liabilities | |||
| Long-Term Debt | 1,812.8 | 1,918.7 | -5.5% |
| Deferred Income Taxes And Other Tax Liabilities Noncurrent | 390.7 | 403.7 | -3.2% |
| Operating Lease Liabilities | 119.6 | 124.6 | -4.0% |
| Other Non-Current Liabilities | 71.7 | 61.9 | +15.8% |
| Total Liabilities | 3,540 | 3,531.1 | +0.3% |
| Long-Term Debt | 1,812.8 | 1,918.7 | -5.5% |
Show Long-Term Debt Type breakouts |
|||
| Senior Notes | 557.8 | 674.2 | -17.3% |
| STE 1.86% due 2027 Senior Notes | 68.9 | 65 | +6.0% |
| STE 2.04% due 2029 Senior Notes | 23 | 21.7 | +6.0% |
| STE 2.30% due 2032 Senior Notes | 21.8 | 20.6 | +5.8% |
| STE 3.04% due 2029 Senior Notes | 59.5 | 58.2 | +2.2% |
| STE 3.17% due 2032 Senior Notes | 39.7 | 38.8 | +2.3% |
| STE 3.55% due 2027 Senior Notes | 125 | 125 | 0.0% |
| STE 3.70% due 2030 Senior Notes | 100 | 100 | 0.0% |
| STE 3.93% due 2027 Senior Notes | 50 | 50 | 0.0% |
| STE 4.03% due 2029 Senior Notes | 45 | 45 | 0.0% |
| STE 4.05% due 2027 Senior Notes | 25 | 25 | 0.0% |
| Accrued Income Taxes Noncurrent | 0.3 | 1.9 | -84.2% |
| Other Liabilities | |||
| Commitments And Contingencies (Q) | — | — | — |
Show Purchase Commitment Excluding Longterm Commitment breakouts |
|||
| Commercial commitments [Member] | 161.3 | 127.4 | +26.6% |
| Long term Construction Contracts [Member] [Member] | 71.5 | — | — |
| Minority Interest | 13.6 | 12.4 | +9.7% |
| Stockholders' Equity | |||
| Common Stock | 4,280.9 | 4,420.4 | -3.2% |
| Retained Earnings | 3,015.9 | 2,475.3 | +21.8% |
| Accumulated Other Comprehensive Income | -113.1 | -292.3 | +61.3% |
| Total Stockholders' Equity | 7,183.6 | 6,603.4 | +8.8% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 7,197.2 | 6,615.8 | +8.8% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -113.1 | -292.3 | +61.3% |
| Common Stock | 4,280.9 | 4,420.4 | -3.2% |
| Noncontrolling Interest | 13.6 | 12.4 | +9.7% |
| Retained Earnings | 3,015.9 | 2,475.3 | +21.8% |
| Total Liabilities & Equity | 10,737.2 | 10,146.8 | +5.8% |
Cash Flow Statement
| Metric | YTD Q4 2026 | YTD Q4 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 123.4 | 122.3 | +0.9% |
Show Business Segments breakouts |
|||
| AST · Segment Continuing Operations | 41.6 | 36.5 | +14.0% |
| Healthcare and Life Sciences · Segment Continuing Operations | 81.9 | 85.8 | -4.5% |
Show Statement Operating Activities Segment breakouts |
|||
| Segment Continuing Operations | 123.4 | 122.3 | +0.9% |
| Deferred Income Taxes | -16.7 | -52.7 | +68.3% |
| Stock-Based Compensation | 12.9 | 9.8 | +31.6% |
| Gain Loss On Sale Of Property Plant Equipment | 0.3 | 2.7 | -88.9% |
| Gain Loss On Disposition Of Business And Equity Investments Net | -0.6 | 10.9 | -105.5% |
| Other Non-Cash Items | -17.8 | 3.5 | -608.6% |
| Change in Accounts Receivable | -123.5 | -108.1 | -14.2% |
| Change in Inventory | 38.5 | 73.8 | -47.8% |
| Change in Prepaid & Other Assets | -32.7 | -31.9 | -2.5% |
| Change in Accounts Payable | 56.9 | 41.1 | +38.4% |
| Increase Decrease In Accrued Liabilities | 74.3 | 43.4 | +71.2% |
| Net Cash from Operations | 335.4 | 260.8 | +28.6% |
| Investing Activities | |||
| Capital Expenditures | -90.2 | -70.9 | -27.2% |
| Payments To Acquire Businesses Net Of Cash Acquired | 0 | -0.4 | +100.0% |
| Net Cash from Investing | -217.2 | -69.8 | -211.2% |
| Financing Activities | |||
| Proceeds From Repayments Of Lines Of Credit | 37.8 | -127.3 | +129.7% |
| Payments Of Merger Related Costs Financing Activities | -0.1 | -0.1 | 0.0% |
| Share Repurchases | -74.3 | -0.2 | -37050.0% |
| Payments Of Dividends Common Stock | -61.8 | -56 | -10.4% |
| Payments To Minority Shareholders | 0 | -0.5 | +100.0% |
| Proceeds From Payments For Other Financing Activities | 0.6 | 6.1 | -90.2% |
| Net Cash from Financing | -97.9 | -178.1 | +45.0% |
| Tax Withholding for Share Compensation | 1.3 | 0.3 | +333.3% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -4.4 | 3.6 | -222.2% |
| Net Change in Cash | 15.9 | 16.5 | -3.6% |
Values in millions USD. Source: SEC EDGAR 10-K filing.